302 related articles for article (PubMed ID: 11522017)
41. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
Humphries SE; Lane A; Dawson S; Green FR
Arch Pathol Lab Med; 1992 Dec; 116(12):1322-9. PubMed ID: 1456879
[TBL] [Abstract][Full Text] [Related]
42. Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain.
Martínez-Calatrava MJ; González-Sánchez JL; Zabena C; Martínez-Larrad MT; Luque-Otero M; Serrano-Ríos M
J Hypertens; 2007 Apr; 25(4):773-7. PubMed ID: 17351368
[TBL] [Abstract][Full Text] [Related]
43. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
[TBL] [Abstract][Full Text] [Related]
44. Failure to lyse venous thrombi because of elevated plasminogen activator Inhibitor 1 (PAI-1) and 4G polymorphism of its promotor genome (The PAI-1/4G Syndrome).
Bern MM; McCarthy N
Clin Appl Thromb Hemost; 2010 Oct; 16(5):574-8. PubMed ID: 20724304
[TBL] [Abstract][Full Text] [Related]
45. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
46. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
47. The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media.
Emonts M; Wiertsema SP; Veenhoven RH; Houwing-Duistermaat JJ; Walraven V; de Groot R; Hermans PW; Sanders EA
Pediatrics; 2007 Aug; 120(2):e317-23. PubMed ID: 17671042
[TBL] [Abstract][Full Text] [Related]
48. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
van Harmelen V; Wahrenberg H; Eriksson P; Arner P
Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
[TBL] [Abstract][Full Text] [Related]
49. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
Kitamura Y; Okumura K; Imamura A; Mizuno T; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T
Clin Chim Acta; 2004 Sep; 347(1-2):209-16. PubMed ID: 15313160
[TBL] [Abstract][Full Text] [Related]
50. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
Espino A; Villagrán A; Vollrath V; Hanckes P; Salas R; Farah A; Solís N; Pizarro M; Escalona A; Boza C; Pérez G; Carrasco G; Padilla O; Miquel JF; Nervi F; Chavez-Tapia NC; Arab JP; Alvarez-Lobos M; Arrese M; Riquelme A
Ann Hepatol; 2011; 10(4):493-501. PubMed ID: 21911891
[TBL] [Abstract][Full Text] [Related]
51. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion.
von Känel R; Maly FE; Frey K; Fischer JE
Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709
[TBL] [Abstract][Full Text] [Related]
52. Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.
Ozolina A; Strike E; Jaunalksne I; Serova J; Romanova T; Zake LN; Sabelnikovs O; Vanags I
Medicina (Kaunas); 2012; 48(10):515-20. PubMed ID: 23324247
[TBL] [Abstract][Full Text] [Related]
53. 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction.
Burzotta F; Di Castelnuovo A; Amore C; D'Orazio A; Di Bitondo R; Donati MB; Iacoviello L
Thromb Haemost; 1998 Feb; 79(2):354-8. PubMed ID: 9493590
[TBL] [Abstract][Full Text] [Related]
54. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
Hamsten A; Syvänne M; Silveira A; Luong LA; Nieminen MS; Humphries S; Frick MH; Taskinen MR
Thromb Haemost; 2000 Mar; 83(3):397-403. PubMed ID: 10744143
[TBL] [Abstract][Full Text] [Related]
55. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
56. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
57. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J
Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
[TBL] [Abstract][Full Text] [Related]
58. Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.
Berberoğlu M; Evliyaoğlu O; Adiyaman P; Ocal G; Ulukol B; Simşek F; Siklar Z; Törel A; Ozel D; Akar N
J Pediatr Endocrinol Metab; 2006 May; 19(5):741-8. PubMed ID: 16789641
[TBL] [Abstract][Full Text] [Related]
59. The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals.
Verschuur M; Jellema A; Bladbjerg EM; M Feskens EJ; Mensink RP; Møller L; Vos HL; de Maat MP
Atherosclerosis; 2005 Aug; 181(2):275-84. PubMed ID: 16039281
[TBL] [Abstract][Full Text] [Related]
60. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
